Military Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Military Industry Today.

Press releases published on October 5, 2026

Oct. 5, 2026

Goldera Expands High-Grade E1 Gold Discovery with Two New Parallel Structures Ahead of Planned Q4 Drilling at Egan Gold Project

Indeterminate GlobeNewswire

Oct. 5, 2026

Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors

Indeterminate GlobeNewswire

Oct. 5, 2026

BBP-418 Demonstrates Potential to Be Disease Modifying Therapy, Restoring Cardiac and Disease Markers to Unaffected Levels

Indeterminate GlobeNewswire

Oct. 5, 2026

Vireo Growth Inc. Announces Financing for New York and Florida Cultivation Facility

Indeterminate GlobeNewswire

Oct. 5, 2026

Terra Clean Energy Contracts KB Drilling for 10,000 Foot Core Drilling Program at Historic Marysvale Uranium Mine Project, Utah, United States

Indeterminate GlobeNewswire

Oct. 5, 2026

Globaltech Corporation Confirms Establishment of Independent Audit, Compensation, and Nominating & Corporate Governance Committees

Indeterminate GlobeNewswire

Oct. 5, 2026

Jiuzi Holdings’ AI Smart Imaging Platform Accelerates Toward Completion: Enterprise-Grade Solution Nears Commercialization; Million-Dollar Profit Expectation Opens New Growth Space

Indeterminate GlobeNewswire

Oct. 5, 2026

FIERCE BIOTECH NAMES REPRONOVO A “FIERCE 15” BIOTECH COMPANY OF 2026

Indeterminate GlobeNewswire

Oct. 5, 2026

Gilat Awarded $28 Million Contract to Expand Connectivity in Peru

Indeterminate GlobeNewswire

Oct. 5, 2026

Kraig Biocraft Laboratories Ramps Full Production Across All Three Production Centers as Commercial Deliveries Begin to Take Hold

Indeterminate GlobeNewswire

Oct. 5, 2026

Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson’s Disease and Movement Disorders

Indeterminate GlobeNewswire

Oct. 5, 2026

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 

Indeterminate GlobeNewswire

Oct. 5, 2026

Coave Therapeutics Presents Non-Human Primate Data Supporting Lead Wet AMD Gene Therapy Program at Euretina 2026

Indeterminate GlobeNewswire

Oct. 5, 2026

Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences

Indeterminate GlobeNewswire

Oct. 5, 2026

Aldebaran Reports 1,728.9 m of 0.45% CuEq (0.41% Cu, 0.03 g/t Au & 1.34 g/t Ag), including 756 m of 0.68% CuEq (0.61% Cu, 0.03 g/t Au & 2.12 g/t Ag) at the Altar Copper-Gold Project in San Juan, Argentina

Indeterminate GlobeNewswire

Oct. 5, 2026

Satellos Granted Composition of Matter Patent for Forazapadin

Indeterminate GlobeNewswire

Oct. 5, 2026

Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial

Indeterminate GlobeNewswire

Oct. 5, 2026

Iridex Completes Relocation of Manufacturing Facility to San Jose, California

Indeterminate GlobeNewswire

Oct. 5, 2026

AIMS Surpasses 185,000 Global Active Traders, Solidifying Its Position as a Leading Regulated Prime Broker

Indeterminate GlobeNewswire

Oct. 5, 2026

Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine

Indeterminate GlobeNewswire